Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Tumor lysis syndrome (TLS)"'
Autor:
Abdulsamad Wafa, Rami A. Jarjour, Doaa Alolabi, Thomas Liehr, Othman Hamdan, Joana B. Melo, Isabel M. Carreira, Moneeb A. K. Othman, Walid Al-Achkar
Publikováno v:
Molecular Cytogenetics, Vol 13, Iss 1, Pp 1-6 (2020)
Abstract Background B cell precursor acute lymphoblastic leukemia (B-ALL) is the most common malignancy of childhood, with, after corresponding treatment, an overall complete remission rate of 90%. Approximately 75% of B-ALL cases harbor recurrent ab
Externí odkaz:
https://doaj.org/article/065fe71f6f684913b1454029df698cf4
Publikováno v:
Diagnostics, Vol 11, Iss 4, p 611 (2021)
Over the last three decades, advancements in the diagnosis, treatment, and supportive care of patients with cancer have significantly improved their overall survival. However, these advancements have also led to a higher rate of cancer-related compli
Externí odkaz:
https://doaj.org/article/80320b0916594dd3a17af07e104e40ff
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Moneeb A.K. Othman, Doaa Alolabi, Abdulsamad Wafa, Isabel M. Carreira, Walid Al-Achkar, Othman Hamdan, Thomas Liehr, Joana B. Melo, Rami A. Jarjour
Publikováno v:
Molecular Cytogenetics, Vol 13, Iss 1, Pp 1-6 (2020)
Molecular Cytogenetics
Molecular Cytogenetics
Background B cell precursor acute lymphoblastic leukemia (B-ALL) is the most common malignancy of childhood, with, after corresponding treatment, an overall complete remission rate of 90%. Approximately 75% of B-ALL cases harbor recurrent abnormaliti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dfe2da4e24ce2435124cac0a55ac314
http://link.springer.com/article/10.1186/s13039-020-00512-3
http://link.springer.com/article/10.1186/s13039-020-00512-3
Publikováno v:
Translational Cancer Research
Tumor lysis syndrome (TLS) is a potentially lethal complication of cancer therapy, and mostly in patients suffering from hematological disease. Acute TLS is a rare complication in the treatment of solid organ tumors, such as hepatocellular carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40173f51a39c5eeafc4d2d29df7e7efb
http://europepmc.org/articles/PMC8797784
http://europepmc.org/articles/PMC8797784
Autor:
Miyuu Tanaka, Ayumi Kaneguchi, Hideo Akiyoshi, Hiroki Yamazaki, Yusuke Wada, Shunsuke Noguchi, Toshiyuki Tanaka
Publikováno v:
The Journal of Veterinary Medical Science
A 13-year-old, female, mixed-breed dog with a huge cranial mediastinal mass underwent radiotherapy (RT). On the following day, the dog presented with lethargy and anorexia. Hematological examination revealed elevated levels of blood urea nitrogen, cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f90acf6266a08006efbbb1a62e6efd0
https://pubmed.ncbi.nlm.nih.gov/34148912
https://pubmed.ncbi.nlm.nih.gov/34148912
Publikováno v:
Translational Cancer Research
Tumor lysis syndrome (TLS) is an oncologic emergency that usually occurs after initial treatment of a malignant tumor. It manifests as hyperuricaemia, hyperkalaemia, hyperphosphataemia and hypocalcaemia, ultimately resulting in acute kidney failure,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab2c36df579a89149d7d338ae1eb5d4b
https://doi.org/10.21037/tcr.2019.07.53
https://doi.org/10.21037/tcr.2019.07.53
Autor:
Dawood Findakly, Jue Wang
Publikováno v:
Cureus
Tumor lysis syndrome (TLS) occurs in rapidly proliferating tumor cells, either spontaneously or after cytotoxic therapy. It has been well-documented in hematological diseases but is extremely rare in solid neoplasms, particularly in prostate cancer (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74ec93126631d2b21dfddbfcf1b63730
https://doi.org/10.7759/cureus.7395
https://doi.org/10.7759/cureus.7395
Publikováno v:
Cureus
Tumor lysis syndrome (TLS) is an oncologic emergency characterized by metabolic and electrolyte abnormalities, observed during the destruction of tumor cells. While it is commonly seen during cytotoxic treatment of hematologic malignancies, it is rar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d9e344d115bb3a1f73c3f7d9858fb9c
https://doi.org/10.7759/cureus.6186
https://doi.org/10.7759/cureus.6186